Developer docs
API playgroundTry for free, no card

Search company profiles

WIN-Partners

Full company profile

uuid003mcwr

Namestring
WIN-Partners
Legal namestring
WIN-Partners Co., Ltd.
Company typeenum
Public
Founded yearint
2013
Descriptiontext

WIN-Partners Co., Ltd. (ウイン・パートナーズ株式会社) is a Tokyo-headquartered holding company that operates a medical device distribution group through five wholly-owned subsidiaries: WIN International, Tesco, Tosei Medical, Trytech, and Plusten Medical. Established in April 2013 through the merger of WIN International and Tesco and listed on the Tokyo Stock Exchange Prime Market (ticker 3183), the group distributes specialized medical devices across five therapeutic categories — PCI (percutaneous coronary intervention for ischemic heart disease), CRS (cardiac rhythm management), CVS (cardiovascular surgery), PPI (peripheral vascular intervention and neurosurgery), and DMS (diabetes management) — plus large medical equipment such as CT scanners. Cardiac-related products account for approximately 67% of FY ending March 2026 sales, and the group claims the No.1 domestic market share in PCI products for minimally invasive treatment of myocardial infarction and angina.

The business model is a direct field sales model in which dedicated sales representatives (MRs) at each subsidiary visit hospitals and clinics to provide pre-sale product consultation, in-surgery standby, and post-sale inventory management. The group's proprietary technology stack includes the WIN Heart Gate consolidated logistics hub near Tokyo Haneda Airport (operational November 2024), the WIN Asset cloud-based medical device and asset management service (launched April 2026), the Master Cloud master data management system, and an RFID-enabled New Logistics Sales System for serial-number-based inventory tracking. Beyond device distribution, subsidiaries provide hospital management consulting support (patient catchment analysis, revenue improvement, operational efficiency) as an embedded demand-generation lever.

Revenue is generated primarily through transactional hardware sales (medical device resale) bundled with clinical proper-use support services. Target customers are acute-care hospitals and recovery-phase clinics across Japan, with no international expansion disclosed. The group also pursues inorganic growth through acquisitions of regional distributors (most recently Plusten Medical in January 2026) and conducts share buybacks as part of its capital return program. As of FY ending March 2026, consolidated net sales are approximately ¥81.4 billion with continued YoY growth projected for FY ending March 2027.

Short descriptiontext

WIN-Partners is a Tokyo-based medical device distribution holding company operating five subsidiaries that sell interventional cardiology, cardiac rhythm, vascular, neurosurgical, and diabetes products to hospitals across Japan, with self-reported #1 domestic PCI market share.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTokyo, Japan
HQ citystring
Tokyo
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device distribution, cardiac catheter products, interventional cardiology, hospital consulting services, medical asset management
Industry1 code
PRIMARYHLAFAAAO
Hospital Shared Services, GPOs & System Support Organizations
Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems
Product category
Medical Device Distribution
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical device distribution (group subsidiaries)
TypeHardware Sales
Description

Five subsidiary companies (WIN International, Tesco, Tosei Medical, Trytech, Plusten Medical) sell medical devices directly to hospitals and clinics. Revenue is generated through the sale of cardiac catheter products (PCI, CRS, CVS), peripheral vascular products (PPI), neurosurgery products, diabetes management products (DMS), and large medical equipment. Cardiac-related products account for approximately 67% of sales (fiscal year ending March 2026). Revenue is transactional per unit sold; the group is a medical device trading company, not a SaaS.

win-partners.co.jp
2Appropriate use support (適正使用支援)
TypeProfessional Services
Description

Group subsidiaries provide clinical support services including pre-surgery planning, device selection, product delivery, in-surgery standby, and post-surgery inventory management. These services are bundled with device sales and strengthen customer retention.

win-partners.co.jp
3Hospital management consulting support
TypeProfessional Services
Description

Subsidiaries provide hospital management advisory services including patient-catchment analysis, revenue improvement, and operational efficiency. These consulting services support sales of medical devices and are embedded in the sales motion.

win-partners.co.jp
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1WIN Asset
Description

Cloud-based medical device and equipment asset management system that supports facilities' DX (digital transformation), inventory management, and traceability.

win-partners.co.jp
+2 more records
Core offering1 text field

WIN-Partners is a medical device distribution group that sells interventional cardiology, cardiac rhythm, cardiovascular surgery, peripheral vascular, neurosurgical, and diabetes management devices to hospitals and clinics across Japan through five specialized subsidiaries. The group supplements device sales with hospital management consulting, proper-use clinical support, and cloud-based asset management (WIN Asset), leveraging its WIN Heart Gate logistics hub for nationwide distribution. PCI products for minimally invasive treatment of myocardial infarction and angina pectoris are the flagship line, holding Japan's No.1 domestic market share.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • PCI products: No.1 domestic market share in Japan for minimally invasive treatment of myocardial infarction and angina (self-reported, source: WIN-Partners)
+4 more records
Product overview1 text field

WIN-Partners is a medical device distributor group (holding company) operating through five subsidiary companies: WIN International, Tesco, Tosei Medical, Trytech, and Plusten Medical. Its core business is the sale of medical devices across five therapeutic segments — PCI (ischemic heart disease), CRS (cardiac rhythm), CVS (cardiovascular surgery), PPI (peripheral vascular/neurosurgery), and DMS (diabetes) — with cardiac-related products accounting for approximately 67% of sales. PCI products hold Japan's top domestic market share (per company research). The portfolio spans catheter-based interventional products (balloon catheters, stents, IVUS), implantable cardiac devices (pacemakers, ICDs, CRT-Ds), cardiac surgery products (stent grafts, TAVI valves, prosthetic valves), embolization coils, and diabetes devices (insulin pumps, CGM). Beyond distribution, the group provides hospital problem-solving support (marketing, profitability consulting) and proper-use support services (device selection, surgical planning, inventory management). A recent addition is WIN Asset, a cloud-based asset management service supporting facility DX.

Product and service9 records
1PCI (Percutaneous Coronary Intervention) Products
CategoryInterventional cardiology medical devices
2CRS (Cardiac Rhythm Segment) Products
CategoryCardiac rhythm management medical devices
3CVS (Cardiac Vascular Segment) Products
CategoryCardiac vascular surgery medical devices
4PPI (Percutaneous Peripheral Intervention) Products
CategoryPeripheral vascular and neurosurgery medical devices
5DMS (Diabetes Mellitus Segment) Products
CategoryDiabetes management medical devices
6Large Medical Equipment (CT)
CategoryLarge medical imaging equipment
7Hospital Problem-Solving Support Services
CategoryHospital consulting services
8Proper Use Support Services
CategoryClinical support services
9WIN Asset
CategoryCloud-based asset management service
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1株式会社プラステンメディカル (Plusten Medical)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Acquired by WIN International (subsidiary) in January 2026 as a subsidiary. Plusten Medical operates in Hokkaido (Hakodate). Group company homepage launched April 2026.

win-partners.co.jp
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-01
Description

Became a subsidiary of WIN-Partners in April 2023. Trytech specializes in neurosurgical and other medical device products, adding neurosurgery segment to the group.

3GX Future Consortium (GXフューチャー・コンソーシアム)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-11-01
Description

WIN-Partners joined the TCFD Consortium, which was reorganized into the GX Future Consortium in April 2024. The consortium supports companies in disclosing climate-related financial information aligned with TCFD recommendations.

win-partners.co.jp
4株式会社トーセイ MEDICAL (Tosei Medical)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-08-01
Description

Acquired by Tesco (subsidiary) in August 2022. Tosei Medical operates in the Tohoku region, expanding Tesco's product and geographic coverage.

win-partners.co.jp
5株式会社ウイン・インターナショナル (WIN International)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-04-01
Description

WIN International is a wholly-owned subsidiary of WIN-Partners, formed through the 2013 merger of WIN International and Tesco into a joint holding company. WIN International handles cardiac catheter products, consumables, and medical equipment planning/sales. It is the primary revenue-generating subsidiary and the entity from which WIN-Partners technically listed (technical IPO).

win-partners.co.jp
6テスコ株式会社 (Tesco)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-04-01
Description

Tesco is a wholly-owned subsidiary of WIN-Partners, established through the 2013 merger. Tesco covers the Tohoku region and handles cardiac and peripheral vascular products. Tesco acquired Tosco Akita Sales (2017), merged it (2018), acquired MCI (2018), acquired Tosei Medical (2022), and merged MCI (March 2026).

win-partners.co.jp
7三菱UFJ銀行 (Mitsubishi UFJ Bank)
Strategic tierMinorTypeOthers
Description

Listed as the primary transaction bank in company profile.

win-partners.co.jp
8三菱UFJ信託銀行株式会社 (Mitsubishi UFJ Trust and Banking)
Strategic tierMinorTypeOthers
Description

Serves as shareholder registry administrator and special account institution.

win-partners.co.jp
9有限責任 あずさ監査法人 (Azsa LLP)
Strategic tierMinorTypeOthers
Description

Statutory accounting auditor for consolidated financial statements.

win-partners.co.jp
Strategic tierMinorTypeOthers
Description

Listed as a major shareholder with 5.8% ownership (as of March 2026, excluding treasury shares).

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
1Alfresa Holdings Corporation
TypeBroad incumbent
Description

Alfresa is a leading Japanese pharmaceutical and medical device wholesaler with nationwide distribution coverage. Overlaps with WIN-Partners in medical device distribution to hospitals and clinics across Japan.

TypeBroad incumbent
Description

Toho Pharmaceutical is a major Japanese pharmaceutical wholesaler with a medical device distribution business. Comparable to WIN-Partners as a healthcare distributor serving Japanese hospitals, though with stronger pharmaceutical weighting.

3Japan Lifeline Co., Ltd.
TypeDirect peer
Description

Japan Lifeline is a Tokyo-listed specialty distributor and manufacturer of cardiovascular medical devices including pacemakers, ICDs, ablation catheters, and stents. Directly comparable to WIN-Partners in the CRS/PCI product categories and Japanese hospital channel.

4Suzuken Co., Ltd.
TypeBroad incumbent
Description

Suzuken is a major Japanese pharmaceutical wholesaler distributing drugs, medical devices, and healthcare products. Comparable to WIN-Partners as a large-scale medical product distributor serving Japanese healthcare providers, though more pharma-skewed.

5Terumo Corporation
TypeOthers
Description

Terumo is a major Japanese medical device manufacturer with significant cardiovascular product lines including stent systems and blood management. Adjacent to WIN-Partners as a key supplier and Japanese cardiovascular device ecosystem participant.

6Medipal Holdings Corporation
TypeBroad incumbent
Description

Medipal is one of Japan's largest pharmaceutical and medical product wholesalers, distributing prescription drugs, OTC, and medical devices to hospitals, clinics, and pharmacies nationwide. It is a broader incumbent in the same Japanese healthcare distribution channel as WIN-Partners.

7Mochida Pharmaceutical Co., Ltd.
TypeBroad incumbent
Description

Mochida operates pharmaceutical manufacturing, sales, and medical device distribution in Japan. Comparable as a Japan-based healthcare distribution business with specialty product overlap, though primarily a manufacturer.

8Asahi Intecc Co., Ltd.
TypeOthers
Description

Asahi Intecc manufactures and globally distributes guidewires, catheters, and other cardiovascular interventional devices. Adjacent comparator in PCI/cath lab supply chain, with overlap in Japanese cardiovascular device end-customers but operating primarily as a manufacturer rather than distributor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

WIN-Partners

Medical Device Distributionwin-partners.co.jp

WIN-Partners is a Tokyo-based medical device distribution holding company operating five subsidiaries that sell interventional cardiology, cardiac rhythm, vascular, neurosurgical, and diabetes products to hospitals across Japan, with self-reported #1 domestic PCI market share.

What WIN-Partners does

WIN-Partners Co., Ltd. (ウイン・パートナーズ株式会社) is a Tokyo-headquartered holding company that operates a medical device distribution group through five wholly-owned subsidiaries: WIN International, Tesco, Tosei Medical, Trytech, and Plusten Medical. Established in April 2013 through the merger of WIN International and Tesco and listed on the Tokyo Stock Exchange Prime Market (ticker 3183), the group distributes specialized medical devices across five therapeutic categories — PCI (percutaneous coronary intervention for ischemic heart disease), CRS (cardiac rhythm management), CVS (cardiovascular surgery), PPI (peripheral vascular intervention and neurosurgery), and DMS (diabetes management) — plus large medical equipment such as CT scanners. Cardiac-related products account for approximately 67% of FY ending March 2026 sales, and the group claims the No.1 domestic market share in PCI products for minimally invasive treatment of myocardial infarction and angina.

The business model is a direct field sales model in which dedicated sales representatives (MRs) at each subsidiary visit hospitals and clinics to provide pre-sale product consultation, in-surgery standby, and post-sale inventory management. The group's proprietary technology stack includes the WIN Heart Gate consolidated logistics hub near Tokyo Haneda Airport (operational November 2024), the WIN Asset cloud-based medical device and asset management service (launched April 2026), the Master Cloud master data management system, and an RFID-enabled New Logistics Sales System for serial-number-based inventory tracking. Beyond device distribution, subsidiaries provide hospital management consulting support (patient catchment analysis, revenue improvement, operational efficiency) as an embedded demand-generation lever.

Revenue is generated primarily through transactional hardware sales (medical device resale) bundled with clinical proper-use support services. Target customers are acute-care hospitals and recovery-phase clinics across Japan, with no international expansion disclosed. The group also pursues inorganic growth through acquisitions of regional distributors (most recently Plusten Medical in January 2026) and conducts share buybacks as part of its capital return program. As of FY ending March 2026, consolidated net sales are approximately ¥81.4 billion with continued YoY growth projected for FY ending March 2027.

WIN-Partners firmographics

Firmographics
Name
WIN-Partners
Legal name
WIN-Partners Co., Ltd.
Website
https://win-partners.co.jp
Company type
Public
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
WIN-Partners is a Tokyo-based medical device distribution holding company operating five subsidiaries that sell interventional cardiology, cardiac rhythm, vascular, neurosurgical, and diabetes products to hospitals across Japan, with self-reported #1 domestic PCI market share.
Ownership category
akta.pro rank

WIN-Partners industry classification

Industry
Product category
Medical Device Distribution
akta.pro industry
PRIMARYHLAFAAAO
Hospital Shared Services, GPOs & System Support Organizations
Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems

Keywords

  • Medical device distribution
  • Cardiac catheter products
  • Interventional cardiology
  • Hospital consulting services
  • Medical asset management

Where WIN-Partners is headquartered

Location

Headquarters

HQ city
Tokyo
HQ country
Japan
HQ region
Asia

Offices5 records

Markets served

WIN-Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical device distribution (group subsidiaries): Five subsidiary companies (WIN International, Tesco, Tosei Medical, Trytech, Plusten Medical) sell medical devices directly to hospitals and clinics. Revenue is generated through the sale of cardiac catheter products (PCI, CRS, CVS), peripheral vascular products (PPI), neurosurgery products, diabetes management products (DMS), and large medical equipment. Cardiac-related products account for approximately 67% of sales (fiscal year ending March 2026). Revenue is transactional per unit sold; the group is a medical device trading company, not a SaaS.
  2. Appropriate use support (適正使用支援): Group subsidiaries provide clinical support services including pre-surgery planning, device selection, product delivery, in-surgery standby, and post-surgery inventory management. These services are bundled with device sales and strengthen customer retention.
  3. Hospital management consulting support: Subsidiaries provide hospital management advisory services including patient-catchment analysis, revenue improvement, and operational efficiency. These consulting services support sales of medical devices and are embedded in the sales motion.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

WIN-Partners product offering

Product offering

Core offering

WIN-Partners is a medical device distribution group that sells interventional cardiology, cardiac rhythm, cardiovascular surgery, peripheral vascular, neurosurgical, and diabetes management devices to hospitals and clinics across Japan through five specialized subsidiaries. The group supplements device sales with hospital management consulting, proper-use clinical support, and cloud-based asset management (WIN Asset), leveraging its WIN Heart Gate logistics hub for nationwide distribution. PCI products for minimally invasive treatment of myocardial infarction and angina pectoris are the flagship line, holding Japan's No.1 domestic market share.

Product overview

WIN-Partners is a medical device distributor group (holding company) operating through five subsidiary companies: WIN International, Tesco, Tosei Medical, Trytech, and Plusten Medical. Its core business is the sale of medical devices across five therapeutic segments — PCI (ischemic heart disease), CRS (cardiac rhythm), CVS (cardiovascular surgery), PPI (peripheral vascular/neurosurgery), and DMS (diabetes) — with cardiac-related products accounting for approximately 67% of sales. PCI products hold Japan's top domestic market share (per company research). The portfolio spans catheter-based interventional products (balloon catheters, stents, IVUS), implantable cardiac devices (pacemakers, ICDs, CRT-Ds), cardiac surgery products (stent grafts, TAVI valves, prosthetic valves), embolization coils, and diabetes devices (insulin pumps, CGM). Beyond distribution, the group provides hospital problem-solving support (marketing, profitability consulting) and proper-use support services (device selection, surgical planning, inventory management). A recent addition is WIN Asset, a cloud-based asset management service supporting facility DX.

Differentiator

Problem solved

Functional benefit

Brands

  • WIN Asset: Cloud-based medical device and equipment asset management system that supports facilities' DX (digital transformation), inventory management, and traceability.
  • WIN Heart Gate (WHG)
  • Shin-Shinshoukun (シン・信蔵君)

Products and services

  • PCI (Percutaneous Coronary Intervention) Products
  • CRS (Cardiac Rhythm Segment) Products
  • CVS (Cardiac Vascular Segment) Products
  • PPI (Percutaneous Peripheral Intervention) Products
  • DMS (Diabetes Mellitus Segment) Products
  • Large Medical Equipment (CT)
  • Hospital Problem-Solving Support Services
  • Proper Use Support Services
  • WIN Asset

Quantifiable outcome

  • PCI products: No.1 domestic market share in Japan for minimally invasive treatment of myocardial infarction and angina (self-reported, source: WIN-Partners)
  • +4 more outcomes

Companies that use WIN-Partners

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

WIN-Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

WIN-Partners partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • 株式会社プラステンメディカル (Plusten Medical)coreStrategic or Co-development Partner · 1 January 2026Acquired by WIN International (subsidiary) in January 2026 as a subsidiary. Plusten Medical operates in Hokkaido (Hakodate). Group company homepage launched April 2026.
  • 株式会社トライテック (Trytech)coreStrategic or Co-development Partner · 1 April 2023Became a subsidiary of WIN-Partners in April 2023. Trytech specializes in neurosurgical and other medical device products, adding neurosurgery segment to the group.
  • GX Future Consortium (GXフューチャー・コンソーシアム)minorStrategic or Co-development Partner · 1 November 2022WIN-Partners joined the TCFD Consortium, which was reorganized into the GX Future Consortium in April 2024. The consortium supports companies in disclosing climate-related financial information aligned with TCFD recommendations.
  • 株式会社トーセイ MEDICAL (Tosei Medical)coreStrategic or Co-development Partner · 1 August 2022Acquired by Tesco (subsidiary) in August 2022. Tosei Medical operates in the Tohoku region, expanding Tesco's product and geographic coverage.
  • 株式会社ウイン・インターナショナル (WIN International)coreStrategic or Co-development Partner · 1 April 2013WIN International is a wholly-owned subsidiary of WIN-Partners, formed through the 2013 merger of WIN International and Tesco into a joint holding company. WIN International handles cardiac catheter products, consumables, and medical equipment planning/sales. It is the primary revenue-generating subsidiary and the entity from which WIN-Partners technically listed (technical IPO).
  • テスコ株式会社 (Tesco)coreStrategic or Co-development Partner · 1 April 2013Tesco is a wholly-owned subsidiary of WIN-Partners, established through the 2013 merger. Tesco covers the Tohoku region and handles cardiac and peripheral vascular products. Tesco acquired Tosco Akita Sales (2017), merged it (2018), acquired MCI (2018), acquired Tosei Medical (2022), and merged MCI (March 2026).
  • 三菱UFJ銀行 (Mitsubishi UFJ Bank)minorOthersListed as the primary transaction bank in company profile.
  • 三菱UFJ信託銀行株式会社 (Mitsubishi UFJ Trust and Banking)minorOthersServes as shareholder registry administrator and special account institution.
  • 有限責任 あずさ監査法人 (Azsa LLP)minorOthersStatutory accounting auditor for consolidated financial statements.
  • グリーンホスピタルサプライ株式会社 (Green Hospital Supply)minorOthersListed as a major shareholder with 5.8% ownership (as of March 2026, excluding treasury shares).

Scale indicators8 records

Recent moves10 records

Expansion highlights6 records

WIN-Partners competitors and assessment

Company assessment

Broad incumbents

  • Alfresa Holdings Corporation: Alfresa is a leading Japanese pharmaceutical and medical device wholesaler with nationwide distribution coverage. Overlaps with WIN-Partners in medical device distribution to hospitals and clinics across Japan.
  • Toho Pharmaceutical Co., Ltd. Toho Pharmaceutical is a major Japanese pharmaceutical wholesaler with a medical device distribution business. Comparable to WIN-Partners as a healthcare distributor serving Japanese hospitals, though with stronger pharmaceutical weighting.
  • Suzuken Co., Ltd. Suzuken is a major Japanese pharmaceutical wholesaler distributing drugs, medical devices, and healthcare products. Comparable to WIN-Partners as a large-scale medical product distributor serving Japanese healthcare providers, though more pharma-skewed.
  • Medipal Holdings Corporation: Medipal is one of Japan's largest pharmaceutical and medical product wholesalers, distributing prescription drugs, OTC, and medical devices to hospitals, clinics, and pharmacies nationwide. It is a broader incumbent in the same Japanese healthcare distribution channel as WIN-Partners.
  • Mochida Pharmaceutical Co., Ltd. Mochida operates pharmaceutical manufacturing, sales, and medical device distribution in Japan. Comparable as a Japan-based healthcare distribution business with specialty product overlap, though primarily a manufacturer.

Direct peers

  • Japan Lifeline Co., Ltd. Japan Lifeline is a Tokyo-listed specialty distributor and manufacturer of cardiovascular medical devices including pacemakers, ICDs, ablation catheters, and stents. Directly comparable to WIN-Partners in the CRS/PCI product categories and Japanese hospital channel.

Others

  • Terumo Corporation: Terumo is a major Japanese medical device manufacturer with significant cardiovascular product lines including stent systems and blood management. Adjacent to WIN-Partners as a key supplier and Japanese cardiovascular device ecosystem participant.
  • Asahi Intecc Co., Ltd. Asahi Intecc manufactures and globally distributes guidewires, catheters, and other cardiovascular interventional devices. Adjacent comparator in PCI/cath lab supply chain, with overlap in Japanese cardiovascular device end-customers but operating primarily as a manufacturer rather than distributor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

WIN-Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

WIN-Partners leadership team

Management profile

Number of profiles

Profiles9 records

WIN-Partners subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

WIN-Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

WIN-Partners M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WIN-Partners

What does WIN-Partners do?

WIN-Partners is a medical device distribution group that sells interventional cardiology, cardiac rhythm, cardiovascular surgery, peripheral vascular, neurosurgical, and diabetes management devices to hospitals and clinics across Japan through five specialized subsidiaries. The group supplements device sales with hospital management consulting, proper-use clinical support, and cloud-based asset management (WIN Asset), leveraging its WIN Heart Gate logistics hub for nationwide distribution. PCI products for minimally invasive treatment of myocardial infarction and angina pectoris are the flagship line, holding Japan's No.1 domestic market share.

Is WIN-Partners a public or private company?

WIN-Partners is a public company. It is classified as public and is currently operating.

When was WIN-Partners founded?

WIN-Partners was founded in 2013. It employs 11 to 50 people.

Where is WIN-Partners based?

WIN-Partners is headquartered in Tokyo, Japan, in the Asia region.

How does WIN-Partners make money?

Three revenue lines are on record. Medical device distribution (group subsidiaries) is the primary driver. The others are appropriate use support (適正使用支援) and hospital management consulting support.

Who are WIN-Partners's main competitors?

Broad incumbents on record are Alfresa Holdings Corporation, Toho Pharmaceutical Co., Ltd., Suzuken Co., Ltd., Medipal Holdings Corporation and Mochida Pharmaceutical Co., Ltd.. Japan Lifeline Co., Ltd. is listed as a direct peer. Others are Terumo Corporation and Asahi Intecc Co., Ltd..

Does WIN-Partners have an API?

No public API is recorded for WIN-Partners.

What industry is WIN-Partners in?

WIN-Partners's product category is Medical Device Distribution. Its primary akta.pro industry code is HLAFAAAO, Hospital Shared Services, GPOs & System Support Organizations.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales